Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2018 $ 85,720 $ 356 $ 239,423 $ (5) $ (5,434) $ (148,620)
Beginning balance, Shares at Jan. 31, 2018   35,634,984        
Adjustment resulting from the adoption of ASC 606 2,319         2,319
Issuance of common stock pursuant to exercise of stock options 54   54      
Issuance of common stock pursuant to exercise of stock options, shares   20,937        
Issuance of common stock pursuant to vesting of restricted stock units   $ 3 (3)      
Issuance of common stock pursuant to exercise of stock options, shares   277,385        
Issuance of common stock pursuant to ESPP purchases 29   29      
Issuance of common stock pursuant to ESPP purchases, Shares   12,794        
Stock-based compensation expense 2,939   2,939      
Unrealized gains (losses) on marketable securities 49       49  
Foreign currency translation adjustment 1,992       1,992  
Net loss (38,002)         (38,002)
Ending balance at Jan. 31, 2019 55,100 $ 359 242,442 (5) (3,393) (184,303)
Ending balance, Shares at Jan. 31, 2019   35,946,100        
Issuance of common stock pursuant to acquisition of Xstream 874 $ 5 869      
Issuance of common stock pursuant to acquisition of Xstreme, Shares   541,738        
Issuance of common stock pursuant to exercise of stock options $ 594 $ 3 591      
Issuance of common stock pursuant to exercise of stock options, shares 195,461 195,461        
Issuance of common stock pursuant to vesting of restricted stock units   $ 6 (6)      
Issuance of common stock pursuant to exercise of stock options, shares   608,200        
Issuance of common stock pursuant to ESPP purchases $ 20   20      
Issuance of common stock pursuant to ESPP purchases, Shares   12,453        
Repurchases of common stock (142)     (142)    
Stock-based compensation expense 1,151   1,151      
Unrealized gains (losses) on marketable securities 44       44  
Foreign currency translation adjustment 1,212       1,212  
Net loss (8,921)         (8,921)
Ending balance at Jan. 31, 2020 $ 49,932 $ 373 $ 245,067 $ (147) $ (2,137) $ (193,224)
Ending balance, Shares at Jan. 31, 2020   37,303,952